CEFTRIAXONE
Antibiotic
Regimen: pid-triple
Strength1000 mg
Forminjection
1 g IM, one part of the three-drug regimen - with doxycycline and metronidazole below, not an alternative to them - Single dose
Adolescent regimen identical to adult dose
WATCH group - carries resistance cost. Egyptian EML 2025.
BASHH UK national guideline for the management of pelvic inflammatory disease, 2018, with the 2019 interim update: "i.m. ceftriaxone 1g single dose followed by oral doxycycline 100mg twice daily plus metronidazole 400mg twice daily for 14 days"
Triple empiric regimen covering N. gonorrhoeae, C. trachomatis, and anaerobic vaginal flora
- 1 g, not 500 mg. BASHH raised the dose in its 2019 interim update; the older 500 mg figure is still widely quoted.
- MUST complete full 14-day oral course of doxycycline and metronidazole even after rapid symptom improvement.
- Screen and treat all sexual partners within past 60 days to prevent reinfection.
- Advise strict avoidance of sexual intercourse until treatment complete and partners treated.
- Inpatient admission is required if the patient is pregnant, a tubo-ovarian abscess is suspected, or she is unable to tolerate the oral regimen.
| Egyptian brand | Manufacturer | Indicative price |
|---|---|---|
| ZOXIDEL 1 GM PD. FOR I.M. INJ. | RAMEDA > DELTA PHARMA | 22.00 EGP |
| CEFTRIAXONE SODIUM 1 GM I.M.VIAL (KAHIRA) | KAHIRA | 29.00 EGP |
| ZOXIDEL 1 GM PD. FOR I.V. INJ. | RAMEDA > DELTA PHARMA | 29.00 EGP |
| WINTRIAXONE 1 GM PD. FOR I.V INJ. | SANOFI | 48.00 EGP |
| VOTRIAXONE 1 GM I.M VIAL | CHEMIPHARM | 56.00 EGP |
| OFRAMAX 1 GM I.M. VIAL | RAMEDA > SUN PHARMA EGYPT LIMITED | 71.00 EGP |
| TRIAXONE 1 GM I.M. VIAL | TABUK PHARMACEUTICAL MANUFACTURING COMPANY > TABUK PHARMA | 106.00 EGP |
| TRIAXONE 1 GM I.V VIAL | TABUK PHARMACEUTICAL MANUFACTURING COMPANY > TABUK PHARMA | 106.00 EGP |